CD95 and CD95L in gastrointestinal cancer patients peripheral blood

被引：0
|
作者：
Jaunalksne, Into [1 ]
Donina, Simona [2 ]
Engele, Ludmila [2 ]
Romanova, Tatjana [2 ]
机构：
[1] Paula Stradina KUS, Riga, Latvia
[2] RAKUS Latvian Oncol Ctr, Riga, Latvia
来源：
CLINICAL IMMUNOLOGY | 2008年 / 127卷
关键词：
D O I：
10.1016/j.clim.2008.03.419
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S146 / S146
页数：1
相关论文
共 50 条
  • [21] Apoptosis in neuroblastomas induced by interferon-γ involves the CD95/CD95L pathway
    Annicchiarico-Petruzzelli, M
    Bernassola, F
    Lovat, PE
    Redfern, CPF
    Pearson, ADJ
    Melino, G
    MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 36 (01): : 115 - 117
  • [22] Characterization of CD95/CD95L expression and apoptosis in T cells of patients with renal carcinoma (RCC)
    Kolenko, V
    Uzzo, RG
    Clark, PE
    Rayman, P
    Bukowski, R
    Tubbs, R
    Novick, AC
    Finke, JH
    JOURNAL OF UROLOGY, 1998, 159 (05): : 172 - 172
  • [23] CD95 is unmutated in cultivated H-RS cells resistant to apoptosis via CD95/CD95L interaction.
    Re, D
    Hofmann, A
    Wolf, J
    Diehl, V
    Jox, A
    BLOOD, 1998, 92 (10) : 189B - 189B
  • [24] Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection
    Cossarizza, A
    Stent, G
    Mussini, C
    Paganelli, R
    Borghi, V
    Nuzzo, C
    Pinti, M
    Pedrazzi, J
    Benatti, F
    Esposito, R
    Rosok, B
    Nagata, S
    Vella, S
    Franceschi, C
    De Rienzo, B
    AIDS, 2000, 14 (04) : 345 - 355
  • [25] Characterization of CD95 ligand (CD95L)-induced apoptosis in human tenon fibroblasts
    Hueber, A
    Welsandt, G
    Jordan, JF
    Mietz, H
    Weller, M
    Krieglstein, GK
    Esser, PJ
    EXPERIMENTAL EYE RESEARCH, 2002, 75 (01) : 1 - 8
  • [26] The role of CD95 and CD95 ligand in cancer
    M E Peter
    A Hadji
    A E Murmann
    S Brockway
    W Putzbach
    A Pattanayak
    P Ceppi
    Cell Death & Differentiation, 2015, 22 : 549 - 559
  • [27] Immunohistochemical analysis of CD30-positive lymphoproliferative disorders for expression of CD95 and CD95L
    Sigel, JE
    Hsi, ED
    MODERN PATHOLOGY, 2000, 13 (04) : 446 - 451
  • [28] The role of CD95 and CD95 ligand in cancer
    Peter, M. E.
    Hadji, A.
    Murmann, A. E.
    Brockway, S.
    Putzbach, W.
    Pattanayak, A.
    Ceppi, P.
    CELL DEATH AND DIFFERENTIATION, 2015, 22 (04): : 549 - 559
  • [29] CD95L/CD95 GENE DELETION DECREASES MOUSE GLIOMA TUMORIGENESIS THROUGH THE INHIBITION OF NON-CANONICAL CD95L/CD95-MEDIATED CELL GROWTH AND IMMUNOSUPPRESSION
    Quijano-Rubio, Clara
    Weller, Michael
    NEURO-ONCOLOGY, 2021, 23 : 37 - 38
  • [30] Carboxy-terminal domain of CD95 suppresses anti-CD95 antibody mediated but not CD95L mediated
    Thilenius, ARB
    Russell, JH
    FASEB JOURNAL, 1996, 10 (06): : 408 - 408
12345